Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The objective of this study was the bioequivalence of a Roxane Laboratories\' Zolpidem Tablets, 10 mg, to Ambien® Tablets, 10 mg (Sanofi-Synthelabo Inc.) under fed conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design.
Epistemonikos ID: 1f143ae8819ca36bcd1904e56660af1b5e01f031
First added on: May 04, 2024